Lakewood Asset Management LLC Gilead Sciences, Inc. Transaction History

Lakewood Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$71.58 - $87.29 $92,910 - $113,302	1,298 Added 18.49%	8,317 $609 Million
Q4 2023 Jan 10, 2024	SELL	$73.27 - $83.09 $40,884 - $46,364	-558 Reduced 7.36%	7,019 $569 Million
Q3 2023 Oct 11, 2023	SELL	$73.94 - $80.67 $1,109 - $1,210	-15 Reduced 0.2%	7,577 $568 Million
Q2 2023 Jul 13, 2023	BUY	$76.01 - $86.7 $2,204 - $2,514	29 Added 0.38%	7,592 $585 Million
Q1 2023 Apr 13, 2023	BUY	$77.31 - $88.08 $2,164 - $2,466	28 Added 0.37%	7,563 $627 Million
Q4 2022 Mar 01, 2023	BUY	$62.32 - $89.47 $469,581 - $674,156	7,535 New	7,535 $647 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Lakewood Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lakewood Asset Management LLC with notifications on news.